Xiaoxin Chen

Dr. Xiaoxin Chen

Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KHKentaro Hirose
Kentaro Hirose
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
CKChakrapani Kalyanaraman
Chakrapani Kalyanaraman
MWMark T. Waddingham
Mark T. Waddingham
MNMakoto Nakamura
Makoto Nakamura
GHGuo N. Huang
Guo N. Huang
Increased mitochondrial biogenesis and aerobic respiration in postnatal mammalian organs are essential for adaptation to extrauterine life, yet the functions of many tissue-enriched, developmentally regulated mitochondrial proteins remain poorly defined. By integrating mitochondrial proteome annotations with mouse and human transcriptomic datasets, we identified Coenzyme Q10a (Coq10a), a striated muscle-enriched mitochondrial protein, as a regulator of postnatal cardiac growth. Coq10a, the mammalian homolog of the yeast ubiquinone-binding protein Coq10p, is highly induced in the heart after birth through thyroid hormone-, Nkx2.5-, and Tbx5-dependent regulation. To define its physiological function, we generated three independent Coq10a -deficient mouse models. Both global and cardiomyocyte-specific loss of Coq10a promoted postnatal cardiac hypertrophy without impairing basal cardiac function or mitochondrial respiration. Instead, Coq10a deficiency altered intracellular ubiquinone partitioning, resulting in increased ubiquinone accumulation in a microsomal membrane fraction. Transcriptomic analyses revealed enrichment of PPAR-associated metabolic gene sets and induction of established PPAR-responsive genes in Coq10a -deficient hearts. Pharmacological inhibition of PPARα and PPARγ, but not PPARδ, attenuated the hypertrophic phenotype. Molecular dynamics simulations, docking analyses, and mutagenesis identified PPARα residues that contribute to differential responsiveness to ubiquinone. Although Coq10a -deficient hearts maintained near-normal function under basal conditions, they exhibited increased susceptibility to pressure-overload stress. Together, these findings establish Coq10a as a regulator of intracellular ubiquinone partitioning and support a model linking altered mitochondrial lipid distribution and PPAR-associated signaling to postnatal cardiac growth. More broadly, they demonstrate how tissue-enriched mitochondrial proteins can mediate organ-specific physiological functions beyond energy production.

18 March 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
XZXiaochen Zhong
Xiaochen Zhong
WYWilliam Yue
William Yue
BWBruce Wang
Bruce Wang
BWBrian Woo
Brian Woo
GHGuo N. Huang
Guo N. Huang
Organ development and function are orchestrated by intricate transcriptional circuits. Here, we present a comprehensive atlas profiling 1,904 transcription regulators in the brain, cerebellum, heart, kidney, liver, ovary, and testis of fetal, neonatal, and adult mice. Using this dataset, we uncover Thymocyte Selection-Associated High Mobility Group Box Family Member 3 (TOX3) as a potential coactivator of Atoh1 in cerebellar granule neuron progenitors (GNPs). Tox3 -deficient mice display severe ataxia and cerebellar hypoplasia, driven by depletion of GNPs, diminished Atoh1 expression, and impaired primary cilia. Single-nucleus RNA-sequencing analyses reveals compromised maintenance of the progenitor pool. TOX3 is also highly expressed in subsets of medulloblastoma, and its deletion reduces cerebellar neoplasia and prolongs survival in a mouse model. Mechanistically, how lineage-defining factors such as Atoh1 drive robust gene expression despite weak intrinsic transactivation activity remains unclear. We show that Tox3 physically associates with Atoh1 and co-occupies shared regulatory elements, converting an otherwise weak single-copy Atoh1-responsive E-box into a highly active enhancer that drives transcriptional activation by up to 120-fold, including at an ultraconserved E-box downstream of Atoh1 itself. Cross-species single-cell comparisons further show an association between Tox3 expression and cerebellum expansion during vertebrate evolution. Together, this work supports Tox3 as a critical Atoh1 coactivator in cerebellar development, tumorigenesis, and evolution, while providing an atlas and screening strategy as a valuable resource for exploring novel transcriptional regulators in organogenesis and tissue physiology.

21 September 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
SYShun Yao
Shun Yao
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
Despite substantial advances in pharmacological therapy, cardiovascular disease remains the leading cause of mortality worldwide. Botanical drugs represent a rich source of structurally diverse bioactive metabolites, yet their translation into modern cardiovascular therapeutics remains limited by chemical complexity, incomplete mechanistic understanding, and challenges in experimental validation. Meanwhile, the rapid expansion of biomedical data resources and advances in artificial intelligence (AI) have created new opportunities to systematically investigate botanical drugs beyond empirical approaches. In this review, we summarize the major biomedical data resources supporting AI-guided ethnopharmacology, including phytochemical and ethnomedicinal databases, multiomics datasets, single-cell and spatial transcriptomics, perturbation-response resources, biological interaction networks, and clinical evidence. We then discuss the computational approaches used for molecular property prediction, drug-target interaction prediction, perturbation-response modeling, and foundation-model transfer learning, highlighting how these complementary strategies address distinct stages of pharmacological discovery. Building on these advances, we propose two complementary AI-guided discovery frameworks: a compound-first strategy that predicts the pharmacological activities of botanical drugs and a disease-first strategy that identifies natural products capable of reversing disease-associated molecular and cellular states. We further discuss emerging applications in cardiovascular diseases, emphasizing the integration of AI with single-cell atlases, disease-state prediction, mechanistic investigation, and experimental validation to prioritize candidate botanical therapeutics. Finally, we outline current challenges in data standardization, model robustness, interpretability, and prospective validation. We propose that AI-guided ethnopharmacology should be viewed as a hypothesis-generation framework that complements, rather than replaces, pharmacological experimentation. When supported by standardized botanical materials, high-quality multimodal data, rigorous biological validation, and prospective clinical evaluation, AI has the potential to accelerate cardiovascular botanical drug discovery and facilitate the translation of ethnomedicinal knowledge into modern precision therapeutics.

15 November 2024 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
XZXiaochen Zhong
Xiaochen Zhong
GHGuo N. Huang
Guo N. Huang
Cardiac regenerative potential in the animal kingdom displays striking divergence across ontogeny and phylogeny. Here we discuss several fundamental questions in heart regeneration and provide both a holistic view of heart regeneration in the organism as a whole, as well as a single-cell perspective on intercellular communication among diverse cardiac cell populations. We hope to provide valuable insights that advance our understanding of organ regeneration and future therapeutic strategies.

14 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EMEmma Faye Murry
Emma Faye Murry
MLMarco A. De Leon
Marco A. De Leon
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
Cell migration contributes to tissue homeostasis, repair, and regeneration by controlling the spatial organization of cells within tissues. Although extensively studied in development and wound healing, migration has received comparatively less attention than proliferation and differentiation in regenerative biology. Migrating cells dynamically regulate polarity, cytoskeletal organization, adhesion, extracellular-matrix interactions, guidance sensing, and metabolism and can move individually or collectively. Importantly, migration can be mechanistically separable from proliferation and, in some regenerative contexts, can precede proliferative expansion. In the heart, cardiomyocytes undergo structural remodeling associated with protrusive and migratory behavior, while vascular, immune, and extracellular-matrix responses shape the regenerative environment. In liver and kidney injury, collective cell migration contributes to early wound closure before substantial proliferation, whereas zebrafish fin and axolotl limb regeneration illustrate how cell movement is coordinated with blastema formation and positional information. In this review, we synthesize the molecular and cellular mechanisms regulating migration during tissue homeostasis, repair, and regeneration and compare individual and collective migration across tissues and species, with particular emphasis on cardiac repair and regeneration. We further discuss experimental approaches, therapeutic opportunities, and outstanding questions. We propose that successful regeneration should be viewed not only as a problem of cell proliferation and differentiation but also as a spatial process requiring regenerative cells to reach appropriate locations and integrate into functional tissue architecture.
1

4 January 2022 in Phytomedicine
Verified
Journal Article
Closed access
Xiaoxin ChenXiaoxin Chen
Xiaoxin Chen
SKSheamin Khyeam
Sheamin Khyeam
ZZZhang-Jin Zhang
Zhang-Jin Zhang
Yanbo ZhangYanbo Zhang
Yanbo Zhang